Several anedoctal reports (Sricker & Spoelestra, 1985) , analyses of vital statistics (Forman et al., 1983) and at least three case-control studies conducted in California (Henderson et al., 1983) and Britain Neuberger et al., 1986) have suggested that the risk of hepatocellular carcinoma is increased in long-term users of oral contraceptives (OC). This association is biologically plausible, since the pill is known to increase substantially the risk of adenomas of the liver (Mettlin & Natarajan, 1981) , and experimental evidence has shown that oral contraceptives are effective promoters of hepatocarcinogenesis in rodents (Yager & Yager, 1980) .
In Italy, the prevalence of OC use has been traditionally low (La Vecchia et al., 1986) . However, inspection of death certification data indicated that the rise in mortality from liver cancer between the late 1950s and the late 1970s was greater in females than in males below age 35, but the opposite was true at later ages (Decarli & La Vecchia, 1984) . Although only about 10 deaths per year in Italian women are attributed to primary liver cancer before age 35, and fewer than 50 below age 45, this pattern of trends prompted us to examine further the relation between oral contraceptives and primary liver cancer, using data from a casecontrol study conducted in Milan.
The data were derived from an ongoing case-control study of several digestive-tract neoplasms, based on a network of teaching and general hospitals in the greater Milan area (La Vecchia et al., 1987) . Between January 1984 and October 1987, 21 female cases of histologically or serologically confirmed primary liver cancer (aged 32-59, median age 50) were interviewed using a structured questionnaire including information on socio-demographic indicators, personal characteristics and habits, selected dietary information, a problem-oriented medical history, and history of use of oral contraceptives and other selected drugs.
The comparison group consisted of 145 women (aged 30-59, median age 50), admitted to a network of hospitals with a catchment area comparable to that of cancer cases, for a wide spectrum of acute, non-neoplastic diseases (37% traumas, 13% other orthopaedics, 40% surgical, 10% other miscellaneous).
Statistical analyses were based on standard methods for case-control studies (Breslow & Day, 1980) . The major findings in relation to oral contraceptive use are given in Table I . There were four (19.0%) cases who had ever used OCs compared with 11 (7.6%) controls. The Hepatitis B serum markers were not determined in this study. A clinical history of hepatitis infection was reported by three (14%) cases and 10 (7%) controls. One case and two controls had evidence of liver cirrhosis. These and other major risk factors for liver cancer in both sexes were considered in a separate paper .
The epidemiology of primary liver cancer in Italy differs from that in Northern European and American countries, Italy having a higher incidence and mortality, probably in consequence of greater prevalence of its major risk factors, i.e. hepatitis B virus and alcohol consumption (La Vecchia & Decarli, 1985; . It is thus interesting to find confirmation in this population of the association between oral contraceptives and hepatocellular carcinoma, although the small absolute numbers and the low prevalence of ever users were major limitations of this study, impeding any analysis of subgroups or interactions. The low prevalence of pill users even among the cases, furthermore, indicates that, although the relative risk was significantly elevated in long-term users, the attributable risk for oral contraceptives is probably small in this population.
